Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05793567 · ClinicalTrials.gov registry record
A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 52
- Enrollment target
NCT05793567: Clinical Trial study, sponsored by Mayo Clinic.
NCT05793567 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05793567 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of this research is to find out if patients with Type 2 Myocardial Infarction (T2MI) without significant epicardial coronary artery disease (CAD) have a greater chance of having coronary microvascular disease (CMD).
Interventions
- DIAGNOSTIC_TEST Coronary angiogram with coronary reactivity testing (CRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05793567
The ClinicalTrials.gov registry entry for NCT05793567 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coronary angiogram with coronary reactivity testing (CRT) is the first listed.
NCT05793567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05793567 about?
NCT05793567 is a clinical study titled "A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)". The purpose of this research is to find out if patients with Type 2 Myocardial Infarction (T2MI) without significant epicardial coronary artery disease (CAD) have a greater chance of having coronary microvascular disease (CMD).
What is the current status of trial NCT05793567?
This trial is currently not yet recruiting. The enrollment target is 52 participants. The study started on 2026-08. Estimated completion is 2027-04.
What interventions are being tested in trial NCT05793567?
The interventions under investigation include: Coronary angiogram with coronary reactivity testing (CRT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05793567?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.